DE102004020160A1 - Verfahren und Vorrichtung zum Überwachen einer Konzentration eines Analyten im lebenden Körper eines Menschen oder Tieres - Google Patents

Verfahren und Vorrichtung zum Überwachen einer Konzentration eines Analyten im lebenden Körper eines Menschen oder Tieres Download PDF

Info

Publication number
DE102004020160A1
DE102004020160A1 DE102004020160A DE102004020160A DE102004020160A1 DE 102004020160 A1 DE102004020160 A1 DE 102004020160A1 DE 102004020160 A DE102004020160 A DE 102004020160A DE 102004020160 A DE102004020160 A DE 102004020160A DE 102004020160 A1 DE102004020160 A1 DE 102004020160A1
Authority
DE
Germany
Prior art keywords
analyte
function
values
determined
value
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE102004020160A
Other languages
German (de)
English (en)
Inventor
Arnulf Staib
Rainer Hegger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diabetes Care GmbH
Original Assignee
Roche Diagnostics GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Diagnostics GmbH filed Critical Roche Diagnostics GmbH
Priority to DE102004020160A priority Critical patent/DE102004020160A1/de
Priority to EP05007701.5A priority patent/EP1589438B1/de
Priority to JP2005117542A priority patent/JP4693474B2/ja
Priority to CA002504661A priority patent/CA2504661C/en
Priority to US11/113,606 priority patent/US7188034B2/en
Publication of DE102004020160A1 publication Critical patent/DE102004020160A1/de
Priority to US11/675,580 priority patent/US7650244B2/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring glucose, e.g. by tissue impedance measurement

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Medical Informatics (AREA)
  • Surgery (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Optics & Photonics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
DE102004020160A 2004-04-24 2004-04-24 Verfahren und Vorrichtung zum Überwachen einer Konzentration eines Analyten im lebenden Körper eines Menschen oder Tieres Withdrawn DE102004020160A1 (de)

Priority Applications (6)

Application Number Priority Date Filing Date Title
DE102004020160A DE102004020160A1 (de) 2004-04-24 2004-04-24 Verfahren und Vorrichtung zum Überwachen einer Konzentration eines Analyten im lebenden Körper eines Menschen oder Tieres
EP05007701.5A EP1589438B1 (de) 2004-04-24 2005-04-08 Verfahren und Vorrichtung zum Überwachen einer Konzentration eines Analyten im lebenden Körper eines Menschen oder Tieres
JP2005117542A JP4693474B2 (ja) 2004-04-24 2005-04-14 ヒトや動物の生体中の被験成分濃度をモニタリングする方法並びにその装置
CA002504661A CA2504661C (en) 2004-04-24 2005-04-21 Method and device for monitoring an analyte concentration in the living body of a human or animal
US11/113,606 US7188034B2 (en) 2004-04-24 2005-04-25 Method and device for monitoring an analyte concentration in the living body of a human or animal
US11/675,580 US7650244B2 (en) 2004-04-24 2007-02-15 Method and device for monitoring analyte concentration by determining its progression in the living body of a human or animal

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102004020160A DE102004020160A1 (de) 2004-04-24 2004-04-24 Verfahren und Vorrichtung zum Überwachen einer Konzentration eines Analyten im lebenden Körper eines Menschen oder Tieres

Publications (1)

Publication Number Publication Date
DE102004020160A1 true DE102004020160A1 (de) 2005-11-10

Family

ID=34934888

Family Applications (1)

Application Number Title Priority Date Filing Date
DE102004020160A Withdrawn DE102004020160A1 (de) 2004-04-24 2004-04-24 Verfahren und Vorrichtung zum Überwachen einer Konzentration eines Analyten im lebenden Körper eines Menschen oder Tieres

Country Status (5)

Country Link
US (2) US7188034B2 (https=)
EP (1) EP1589438B1 (https=)
JP (1) JP4693474B2 (https=)
CA (1) CA2504661C (https=)
DE (1) DE102004020160A1 (https=)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007046864A1 (de) * 2007-09-28 2009-04-09 Endress + Hauser Conducta Gesellschaft für Mess- und Regeltechnik mbH + Co. KG Verfahren und Vorrichtung zur Bewertung eines Messwertes
US8477026B2 (en) 2007-03-09 2013-07-02 Roche Diagnostics Operations, Inc. Medical data transmission system

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6391005B1 (en) 1998-03-30 2002-05-21 Agilent Technologies, Inc. Apparatus and method for penetration with shaft having a sensor for sensing penetration depth
US8641644B2 (en) 2000-11-21 2014-02-04 Sanofi-Aventis Deutschland Gmbh Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means
US9427532B2 (en) 2001-06-12 2016-08-30 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US7981056B2 (en) 2002-04-19 2011-07-19 Pelikan Technologies, Inc. Methods and apparatus for lancet actuation
AU2002315180A1 (en) 2001-06-12 2002-12-23 Pelikan Technologies, Inc. Electric lancet actuator
US9795747B2 (en) 2010-06-02 2017-10-24 Sanofi-Aventis Deutschland Gmbh Methods and apparatus for lancet actuation
DE60234598D1 (de) 2001-06-12 2010-01-14 Pelikan Technologies Inc Selbstoptimierende lanzettenvorrichtung mit adaptationsmittel für zeitliche schwankungen von hauteigenschaften
US7025774B2 (en) 2001-06-12 2006-04-11 Pelikan Technologies, Inc. Tissue penetration device
EP1404235A4 (en) 2001-06-12 2008-08-20 Pelikan Technologies Inc METHOD AND DEVICE FOR A LANZETTING DEVICE INTEGRATED ON A BLOOD CARTRIDGE CARTRIDGE
US8337419B2 (en) 2002-04-19 2012-12-25 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US9226699B2 (en) 2002-04-19 2016-01-05 Sanofi-Aventis Deutschland Gmbh Body fluid sampling module with a continuous compression tissue interface surface
US7331931B2 (en) 2002-04-19 2008-02-19 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8579831B2 (en) 2002-04-19 2013-11-12 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US8784335B2 (en) 2002-04-19 2014-07-22 Sanofi-Aventis Deutschland Gmbh Body fluid sampling device with a capacitive sensor
US7175642B2 (en) 2002-04-19 2007-02-13 Pelikan Technologies, Inc. Methods and apparatus for lancet actuation
US8360992B2 (en) 2002-04-19 2013-01-29 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US8702624B2 (en) 2006-09-29 2014-04-22 Sanofi-Aventis Deutschland Gmbh Analyte measurement device with a single shot actuator
US7297122B2 (en) 2002-04-19 2007-11-20 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7976476B2 (en) 2002-04-19 2011-07-12 Pelikan Technologies, Inc. Device and method for variable speed lancet
US7892185B2 (en) 2002-04-19 2011-02-22 Pelikan Technologies, Inc. Method and apparatus for body fluid sampling and analyte sensing
US7674232B2 (en) 2002-04-19 2010-03-09 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8221334B2 (en) 2002-04-19 2012-07-17 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7198606B2 (en) 2002-04-19 2007-04-03 Pelikan Technologies, Inc. Method and apparatus for a multi-use body fluid sampling device with analyte sensing
US9795334B2 (en) 2002-04-19 2017-10-24 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7901362B2 (en) 2002-04-19 2011-03-08 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7909778B2 (en) 2002-04-19 2011-03-22 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7491178B2 (en) 2002-04-19 2009-02-17 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US9248267B2 (en) 2002-04-19 2016-02-02 Sanofi-Aventis Deustchland Gmbh Tissue penetration device
US7892183B2 (en) 2002-04-19 2011-02-22 Pelikan Technologies, Inc. Method and apparatus for body fluid sampling and analyte sensing
US7232451B2 (en) 2002-04-19 2007-06-19 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7229458B2 (en) 2002-04-19 2007-06-12 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8267870B2 (en) 2002-04-19 2012-09-18 Sanofi-Aventis Deutschland Gmbh Method and apparatus for body fluid sampling with hybrid actuation
US7547287B2 (en) 2002-04-19 2009-06-16 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US9314194B2 (en) 2002-04-19 2016-04-19 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US8574895B2 (en) 2002-12-30 2013-11-05 Sanofi-Aventis Deutschland Gmbh Method and apparatus using optical techniques to measure analyte levels
DE602004028463D1 (de) 2003-05-30 2010-09-16 Pelikan Technologies Inc Verfahren und vorrichtung zur injektion von flüssigkeit
WO2004107964A2 (en) 2003-06-06 2004-12-16 Pelikan Technologies, Inc. Blood harvesting device with electronic control
WO2006001797A1 (en) 2004-06-14 2006-01-05 Pelikan Technologies, Inc. Low pain penetrating
US8282576B2 (en) 2003-09-29 2012-10-09 Sanofi-Aventis Deutschland Gmbh Method and apparatus for an improved sample capture device
EP1680014A4 (en) 2003-10-14 2009-01-21 Pelikan Technologies Inc METHOD AND DEVICE FOR A VARIABLE USER INTERFACE
EP1706026B1 (en) 2003-12-31 2017-03-01 Sanofi-Aventis Deutschland GmbH Method and apparatus for improving fluidic flow and sample capture
US7822454B1 (en) 2005-01-03 2010-10-26 Pelikan Technologies, Inc. Fluid sampling device with improved analyte detecting member configuration
WO2006011062A2 (en) 2004-05-20 2006-02-02 Albatros Technologies Gmbh & Co. Kg Printable hydrogel for biosensors
WO2005120365A1 (en) 2004-06-03 2005-12-22 Pelikan Technologies, Inc. Method and apparatus for a fluid sampling device
US9775553B2 (en) 2004-06-03 2017-10-03 Sanofi-Aventis Deutschland Gmbh Method and apparatus for a fluid sampling device
US8652831B2 (en) 2004-12-30 2014-02-18 Sanofi-Aventis Deutschland Gmbh Method and apparatus for analyte measurement test time
EP1728468A1 (de) * 2005-06-04 2006-12-06 Roche Diagnostics GmbH Bewertung von Werten der Blutglucosekonzentration zur Einstellung der Insulindosierung
WO2008017981A2 (en) * 2006-08-08 2008-02-14 Koninklijke Philips Electronics N.V. Method and device for monitoring a physiological parameter
US8439837B2 (en) * 2006-10-31 2013-05-14 Lifescan, Inc. Systems and methods for detecting hypoglycemic events having a reduced incidence of false alarms
EP3391812B1 (en) * 2007-01-23 2025-01-01 Ascensia Diabetes Care Holdings AG Analyte-testing device
US20090160656A1 (en) * 2007-10-11 2009-06-25 Mahesh Seetharaman Analyte monitoring system alarms
US7731659B2 (en) * 2007-10-18 2010-06-08 Lifescan Scotland Limited Method for predicting a user's future glycemic state
US7695434B2 (en) * 2007-10-19 2010-04-13 Lifescan Scotland, Ltd. Medical device for predicting a user's future glycemic state
WO2009126900A1 (en) 2008-04-11 2009-10-15 Pelikan Technologies, Inc. Method and apparatus for analyte detecting device
WO2010014963A2 (en) * 2008-07-31 2010-02-04 Government Of The United States As Represented By The Secretary Of The Army Universal models for predicting glucose concentration in humans
US9375169B2 (en) 2009-01-30 2016-06-28 Sanofi-Aventis Deutschland Gmbh Cam drive for managing disposable penetrating member actions with a single motor and motor and control system
JP5410511B2 (ja) 2009-04-17 2014-02-05 アークレイ株式会社 情報提供システム、情報提供方法、プログラム及びサーバ装置
US8843321B2 (en) * 2010-01-26 2014-09-23 Roche Diagnostics Operations, Inc. Methods and systems for processing glucose data measured from a person having diabetes
US8965476B2 (en) 2010-04-16 2015-02-24 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
EP2700031A2 (en) * 2011-04-20 2014-02-26 Novo Nordisk A/S Glucose predictor based on regularization networks with adaptively chosen kernels and regularization parameters
KR101962315B1 (ko) * 2017-03-29 2019-07-17 이화여자대학교 산학협력단 혈중수은농도 예측방법

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI931234A7 (fi) 1993-03-19 1994-09-20 Instr Oy Menetelmä potilaan tilan seuraamiseksi
KR0142483B1 (ko) 1994-02-28 1998-08-17 고지마 게이지 시계열 데이타의 단기 예측을 실행하기 위한 방법 및 장치
DE4415896A1 (de) 1994-05-05 1995-11-09 Boehringer Mannheim Gmbh Analysesystem zur Überwachung der Konzentration eines Analyten im Blut eines Patienten
EP0910023A2 (de) * 1997-10-17 1999-04-21 Siemens Aktiengesellschaft Verfahren und Anordnung zur neuronalen Modellierung eines dynamischen Systems mit nichtlinearem stochastischem Verhalten
JPH11296598A (ja) 1998-04-07 1999-10-29 Seizaburo Arita 血糖値の予測システム及び予測方法並びにこの方法を記録した記録媒体
EP1078258B1 (en) 1998-05-13 2003-07-30 Cygnus, Inc. Device for predicting physiological values
US6925393B1 (en) 1999-11-18 2005-08-02 Roche Diagnostics Gmbh System for the extrapolation of glucose concentration
JP3563333B2 (ja) 2000-08-04 2004-09-08 Ｎｅｃエレクトロニクス株式会社 インラッシュ電流対応ハイサイドスイッチ及び過電流制御方法
ES2304394T3 (es) 2000-08-18 2008-10-16 Animas Technologies Llc Dispositivo para la prediccion de eventos hipoglucemicos.
EP1702561B1 (en) 2002-03-22 2011-05-04 Animas Technologies LLC Improving performance for an analyte monitoring device
US7278983B2 (en) * 2002-07-24 2007-10-09 Medtronic Minimed, Inc. Physiological monitoring device for controlling a medication infusion device
AU2003259741B2 (en) 2002-08-13 2008-10-23 University Of Virginia Patent Foundation Managing and processing self-monitoring blood glucose
DE10343863A1 (de) * 2003-09-23 2005-04-14 Roche Diagnostics Gmbh Verfahren und Gerät zur laufenden Überwachung der Konzentration eines Analyten
US20070060870A1 (en) * 2005-08-16 2007-03-15 Tolle Mike Charles V Controller device for an infusion pump
US20070060869A1 (en) * 2005-08-16 2007-03-15 Tolle Mike C V Controller device for an infusion pump

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8477026B2 (en) 2007-03-09 2013-07-02 Roche Diagnostics Operations, Inc. Medical data transmission system
DE102007046864A1 (de) * 2007-09-28 2009-04-09 Endress + Hauser Conducta Gesellschaft für Mess- und Regeltechnik mbH + Co. KG Verfahren und Vorrichtung zur Bewertung eines Messwertes

Also Published As

Publication number Publication date
CA2504661C (en) 2009-08-18
EP1589438B1 (de) 2015-11-04
US7650244B2 (en) 2010-01-19
EP1589438A2 (de) 2005-10-26
US20050240356A1 (en) 2005-10-27
CA2504661A1 (en) 2005-10-24
JP4693474B2 (ja) 2011-06-01
US20070148778A1 (en) 2007-06-28
JP2005308742A (ja) 2005-11-04
EP1589438A3 (de) 2006-03-22
US7188034B2 (en) 2007-03-06

Similar Documents

Publication Publication Date Title
EP1589438B1 (de) Verfahren und Vorrichtung zum Überwachen einer Konzentration eines Analyten im lebenden Körper eines Menschen oder Tieres
EP1518495B1 (de) Verfahren und Gerät zur laufenden Überwachung der Konzentration eines Analyten
DE69802428T2 (de) Verfahren und gerät zur verminderung von alarmmisständen
EP2835143B1 (de) Vorrichtung zur Vorhersage intradialytischer Parameter
DE3785717T2 (de) Mehrfach-Pulsverfahren und Gerät angewendet in der Oximetrie.
EP1702559B1 (de) Verfahren und System zur Untersuchung des Glucosestoffwechsels
EP2470913B1 (de) Kalibrierverfahren zur prospektiven Kalibrierung eines Messgeräts, Computerprogramm und Messgerät
WO2000077659A1 (de) Qualitätsindikator für messsignale, insbesondere medizinische messsignale wie aus der sauerstoffsättigungsmessung
EP2050384A1 (de) Verfahren zur Speicherung einer Messreihe
EP1097439B1 (de) Verfahren und vorrichtung zur erkennung von driften, sprüngen und/oder ausreissern von messwerten
DE2849367B2 (de) Vorrichtung zur Regelung der Glucosekonzentration im Blutstrom einer Person
DE69202558T2 (de) Verfahren zum Messen von Artefakten in einem Blutdruckmessystem.
EP2433557A1 (de) Verfahren und Anordnung zur Ermittlung von phasenspezifischen Parametern einer physiologischen Größe sowie ein entsprechendes Computerprogramm und ein entsprechendes computerlesbares Speichermedium
WO1999014686A2 (de) Verfahren zur erfassung zeitabhängiger moden dynamischer systeme
DE10114383B4 (de) Blutdruckvorrichtung und Gerät zur extrakorporalen Blutbehandlung mit einer solchen Blutüberwachungsvorrichtung
DE3511697A1 (de) Verfahren zur automatischen verarbeitung elektrookulografischer signale
EP2251806A1 (de) Verfahren und Anordnung zur Vorhersage mindestens eines Systemereignisses sowie ein entsprechendes Computerprogramm und ein entsprechendes computerlesbares Speichermedium
EP1192897A2 (de) Risikomonitoring
EP1793321B1 (de) Auswerteverfahren und Untersuchungssystem eines Analyten im Körperflüssigkeit eines Menschen oder Tieres
DE112016002971T5 (de) Einrichtung zur Erfassung viskoelastischer Eigenschaften, Verfahren zur Erfassung viskoelastischer Eigenschaften, Programm zur Erfassung viskoelastischer Eigenschaften und Aufzeichnungsmedium für die Aufzeichnung des Programms
DE19839047A1 (de) Verfahren und Vorrichtung zur Drifterkennung
AT406634B (de) Verfahren und schaltungsanordnung zur erzeugung eines den herzschlag repräsentierenden signales
EP0646261B1 (de) Verfahren und einrichtung zur analyse von hochdynamischen sekretionsphänomenen von hormonen in biologischen dynamischen systemen mittels biosensoren
WO2022199765A1 (de) Verfahren zum bestimmen eines aktuellen glukosewerts in einem transportfluid
DE102021120512A1 (de) Bewertungseinheit für ein medizinisches System

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
R012 Request for examination validly filed

Effective date: 20110210

8125 Change of the main classification

Ipc: G06F 17/17 AFI20040424BHDE

R079 Amendment of ipc main class

Free format text: PREVIOUS MAIN CLASS: G06F0019000000

Ipc: G06F0017170000

Effective date: 20110330

R016 Response to examination communication
R016 Response to examination communication
R081 Change of applicant/patentee

Owner name: ROCHE DIABETES CARE GMBH, DE

Free format text: FORMER OWNER: ROCHE DIAGNOSTICS GMBH, 68305 MANNHEIM, DE

R082 Change of representative

Representative=s name: TWELMEIER MOMMER & PARTNER PATENT- UND RECHTSA, DE

R120 Application withdrawn or ip right abandoned